Suzhou Three Stooges Biotechnology
Innovative contact lens care and eye health solutions
About Suzhou Three Stooges Biotechnology
Suzhou Three Stooges Biotechnology Co., Ltd., also known as 3N, is a high-tech company focused on eye health, particularly contact lens care. The company was established in 2015, following research that began in 2013 on applying electrophoresis technology to remove protein deposits from contact lenses. A key milestone was the successful development of the Elepy® technology in 2017, a unique method for active, high-efficiency protein removal and sterilization of lenses.
The company's business is centered on the research, development, production, and marketing of eye care products. It offers a range of products for soft, rigid, and scleral contact lenses, as well as solutions for dry eye care. Its product lineup includes various generations of the 3N contact lens cleaning device and a nebulizer for dry eye relief. The business model involves selling these products through multiple online channels, including its own e-commerce stores on platforms like Tmall, JD.com, and Xiaomi Youpin, as well as a presence on social commerce sites like Xiaohongshu. The company's market reach is global, with its products sold in over 30 countries to more than one million users.
A significant achievement for 3N was receiving FDA certification in 2022 for its active contact lens care device, noted as the first of its kind globally. The company has been recognized as a National High-tech Enterprise and has received several awards, including the Jiangsu Provincial Medical Science and Technology Progress Award. It holds numerous patents in the US, Japan, and Europe.
Source: Dealroom company dataNews
Open roles
Suzhou Three Stooges Biotechnology in the Suzhou Shi ecosystem
The Suzhou Three Stooges Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Pan-Lin Asset Management- SCShenzhen Venture Capital
- KCKaicheng Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Suzhou Three Stooges Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Suzhou Three Stooges Biotechnology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.